Latest Reports

The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking. 

It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations. 

This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment. 

The “2026 IOL Market Report” delivers a comprehensive, data-driven view of the global intraocular lens market, combining detailed analysis of today’s landscape with five-year forecasts designed to inform strategy, investment, and competitive positioning. 

Built on Market Scope’s proprietary models and deep industry insight, the report identifies the trends shaping demand, tracks shifts in technology adoption, and highlights the factors that will define success in an increasingly competitive and innovation-driven market. 

The analysis segments the market across 11 distinct IOL categories—commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs— to provide a clear view of where growth is occurring and how the premium market continues to evolve. 

In addition, the report profiles 40 leading companies, offering insight into their product portfolios, strategic positioning, competitive strengths, and future outlook to provide you with the intelligence needed to benchmark competitors and identify opportunities in the global IOL market. 

Market Scope’s first-edition “2026 Myopia Management Market Report” provides a data-driven view of one of ophthalmology’s fastest-growing segments, with a focus on the rising pediatric myopia population and the shift toward earlier intervention. It quantifies the total, addressable, and serviceable markets, with five-year forecasts and detailed analysis of treatment volumes, adoption trends, and competitive dynamics across key regions.  

The report provides deep segmentation across all major treatment categories—including myopia control spectacles, soft contact lenses, orthokeratology, and low-dose atropine—alongside insights into combination therapies, treatment efficacy, reimbursement, and barriers to adoption. It also examines the underlying drivers shaping demand, from demographic and lifestyle trends to provider behavior and access to care.  

Expanded coverage of diagnostic technologies, digital platforms, and emerging therapies paired with global market analysis and company profiles gives you a complete picture of where the market is today and where it’s headed.  

The “2026 Retinal Device Market Report” provides a comprehensive, data-driven analysis of the global retinal device market, including market size, growth trends, and the key developments shaping future demand for major product segments such as vitrectomy machines, vitrectomy packs, accessories and allied surgical products, tamponades, retinal medical devices, maintenance and upgrade revenue, and other surgical devices. It also evaluates the current competitive landscape and provides detailed forecasts through 2031, offering clear insight into how the market is expected to evolve over the next five years. 

In addition, the report profiles 19 leading retinal device companies, with in-depth coverage of their product portfolios, strategic positioning, company background, and outlook to provide a clear view of the competitive dynamics driving the market forward. 

The “2026 European Five Ophthalmic Market Report” delivers a comprehensive, data-driven view of Western Europe’s five largest ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—across 11 key submarkets. The report analyzes current market dynamics, identifies the trends shaping demand, and provides clear forecasts through 2031 to support strategic planning and competitive positioning. 

In addition, the report includes detailed disease prevalence forecasts, treatment and procedure volume analysis, emerging technology assessment, and in-depth profiles of leading competitors to provide a complete picture of how these major European markets are evolving and where the strongest opportunities are expected to emerge. 

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

The "2026 United States Optometry Trends Survey Report" delivers a data-driven view of how optometry practices are structured and evolving—highlighting key trends in clinical care, technology adoption, referral patterns, and growth dynamics. 

Built on extensive primary research and featuring expert commentary from Market Scope, this report explores brand decision drivers and service offerings across medical eye care, contact lenses, dry eye, and myopia management.  

The report also connects optometry to the broader ophthalmic ecosystem, offering unique insight into co-management patterns, cataract and refractive referral behavior, and the factors that drive surgeon selection and premium IOL conversion.  

The “2026 Glaucoma Pharmaceuticals Market Report” provides a data-driven view of the global and regional glaucoma drug markets, highlighting the trends and competitive forces shaping future growth. The report includes forecasts through 2031 across all major therapy classes, including prostaglandins (branded and generic), beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combinations, NO-donating compounds, and Rho-kinase inhibitors. 

In addition, the report examines a robust development pipeline of over 30 drug candidates and profiles 23 leading companies, providing insight into product portfolios, strategic positioning, and future outlook. 

The "2025 India Ophthalmic Market Report" delivers a comprehensive analysis of India’s ophthalmic market, highlighting key trends, competitive dynamics, and factors shaping future growth. The report includes forecasts for disease prevalence, procedure volumes, and technology adoption across diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. 

Profiles of 30 leading competitors provide insight into product portfolios, strategic positioning, and market outlook. 

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.